Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension

The gut microbial metabolite trimethylamine N-oxide (TMAO) is regarded as a novel risk factor for hypertension. Berberine (BBR) exerts cardiovascular protective effects by regulating the gut microbiota-metabolite production pathway. However, whether and how BBR alleviates TMAO-induced vascular dysfu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microbiological research 2024-10, Vol.287, p.127824, Article 127824
Hauptverfasser: Wang, Zhichao, Shao, Yijia, Wu, Fang, Luo, Dangu, He, Guoyifan, Liang, Jianwen, Quan, Xiaoqing, Chen, Xiehui, Xia, Wenhao, Chen, Ye, Liu, Yue, Chen, Long
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 127824
container_title Microbiological research
container_volume 287
creator Wang, Zhichao
Shao, Yijia
Wu, Fang
Luo, Dangu
He, Guoyifan
Liang, Jianwen
Quan, Xiaoqing
Chen, Xiehui
Xia, Wenhao
Chen, Ye
Liu, Yue
Chen, Long
description The gut microbial metabolite trimethylamine N-oxide (TMAO) is regarded as a novel risk factor for hypertension. Berberine (BBR) exerts cardiovascular protective effects by regulating the gut microbiota-metabolite production pathway. However, whether and how BBR alleviates TMAO-induced vascular dysfunction in hypertension remains unclear. In the present study, we observed that plasma TMAO and related bacterial abundance were significantly elevated and negatively correlated with vascular function in 86 hypertensive patients compared with 46 normotensive controls. TMAO activated endoplasmic reticulum stress (ERS) signaling pathway to promote endothelial cell dysfunction and apoptosis in vitro. BBR (100, 200 mg · kg−1 ·d−1) for 4 weeks ameliorates TMAO-induced vascular dysfunction and ERS activation in a choline-angiotensin II hypertensive mouse model. We found that plasma TMAO levels in 15 hypertensive patients treated with BBR (0.4 g, tid) were reduced by 8.8 % and 16.7 % at months 1 and 3, respectively, compared with pretreatment baseline. The oral BBR treatment also improved vascular function and lowered blood pressure. Faecal 16 S rDNA showed that BBR altered the gut bacterial composition and reduced the abundance of CutC/D bacteria in hypertensive mice and patients. In vitro bacterial cultures and enzyme reaction systems indicated that BBR inhibited the biosynthesis of TMAO precursor in the gut microbiota by binding to and inhibiting the activity of CutC/D enzyme. Our results indicate that BBR improve vascular dysfunction at least partially by decreasing TMAO via regulation of the gut microbiota in hypertension. [Display omitted] •Circulating TMAO and related bacterial abundance were elevated and associated with vascular dysfunction in hypertension.•TMAO activated endoplasmic reticulum stress to promote endothelial cell dysfunction and apoptosis.•BBR reduced plasma TMAO by decreasing abundance of CutC/D bacteria and inhibiting CutC/D enzyme activity in gut microbiota.•BBR had a protective effect against TMAO-induced vascular dysfunction and endoplasmic reticulum stress activation in hypertension.
doi_str_mv 10.1016/j.micres.2024.127824
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3084770930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0944501324002258</els_id><sourcerecordid>3084770930</sourcerecordid><originalsourceid>FETCH-LOGICAL-c287t-e0ec1b77d8baf3168813954ae85e13418918741c0d9d312f9cca4c900c7d483e3</originalsourceid><addsrcrecordid>eNp9Uc1u1DAQthCIbgtvgJCPXLK1Y29sX5BKBbRSUS_t2XLsydarxAm2s1UegbeuVykcOc1hvr-ZD6FPlGwpoc3lYTt4GyFta1LzLa2FrPkbtKENlRVpavYWbYjivNoRys7QeUoHQihXsn6PzpgiO0ZEs0F_vkFsIfoA2AzQ-zGaDAkfTbJzbyJ2S-rmYLMfA24X7MbnEGFfVtmHPX74dXVfQXDj1JtU4uAI2RfiPOCUS7aEJ5Ofns2Cj97g_ZzxKfPY-jEb7AN-WiaIGUIq8h_Qu870CT6-zgv0-OP7w_VNdXf_8_b66q6ytRS5AgKWtkI42ZqO0UZKytSOG5A7oIxTqagUnFrilGO07pS1hltFiBWOSwbsAn1Zdac4_p4hZT34ZKHvTYBxTpoRyYUgipEC5Su0ZE4pQqen6AcTF02JPpWgD3otQZ9K0GsJhfb51WFuB3D_SH-_XgBfVwCUO48eok7WQ7DgfASbtRv9_x1eACtOncw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3084770930</pqid></control><display><type>article</type><title>Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension</title><source>Elsevier ScienceDirect Journals</source><creator>Wang, Zhichao ; Shao, Yijia ; Wu, Fang ; Luo, Dangu ; He, Guoyifan ; Liang, Jianwen ; Quan, Xiaoqing ; Chen, Xiehui ; Xia, Wenhao ; Chen, Ye ; Liu, Yue ; Chen, Long</creator><creatorcontrib>Wang, Zhichao ; Shao, Yijia ; Wu, Fang ; Luo, Dangu ; He, Guoyifan ; Liang, Jianwen ; Quan, Xiaoqing ; Chen, Xiehui ; Xia, Wenhao ; Chen, Ye ; Liu, Yue ; Chen, Long</creatorcontrib><description>The gut microbial metabolite trimethylamine N-oxide (TMAO) is regarded as a novel risk factor for hypertension. Berberine (BBR) exerts cardiovascular protective effects by regulating the gut microbiota-metabolite production pathway. However, whether and how BBR alleviates TMAO-induced vascular dysfunction in hypertension remains unclear. In the present study, we observed that plasma TMAO and related bacterial abundance were significantly elevated and negatively correlated with vascular function in 86 hypertensive patients compared with 46 normotensive controls. TMAO activated endoplasmic reticulum stress (ERS) signaling pathway to promote endothelial cell dysfunction and apoptosis in vitro. BBR (100, 200 mg · kg−1 ·d−1) for 4 weeks ameliorates TMAO-induced vascular dysfunction and ERS activation in a choline-angiotensin II hypertensive mouse model. We found that plasma TMAO levels in 15 hypertensive patients treated with BBR (0.4 g, tid) were reduced by 8.8 % and 16.7 % at months 1 and 3, respectively, compared with pretreatment baseline. The oral BBR treatment also improved vascular function and lowered blood pressure. Faecal 16 S rDNA showed that BBR altered the gut bacterial composition and reduced the abundance of CutC/D bacteria in hypertensive mice and patients. In vitro bacterial cultures and enzyme reaction systems indicated that BBR inhibited the biosynthesis of TMAO precursor in the gut microbiota by binding to and inhibiting the activity of CutC/D enzyme. Our results indicate that BBR improve vascular dysfunction at least partially by decreasing TMAO via regulation of the gut microbiota in hypertension. [Display omitted] •Circulating TMAO and related bacterial abundance were elevated and associated with vascular dysfunction in hypertension.•TMAO activated endoplasmic reticulum stress to promote endothelial cell dysfunction and apoptosis.•BBR reduced plasma TMAO by decreasing abundance of CutC/D bacteria and inhibiting CutC/D enzyme activity in gut microbiota.•BBR had a protective effect against TMAO-induced vascular dysfunction and endoplasmic reticulum stress activation in hypertension.</description><identifier>ISSN: 0944-5013</identifier><identifier>ISSN: 1618-0623</identifier><identifier>EISSN: 1618-0623</identifier><identifier>DOI: 10.1016/j.micres.2024.127824</identifier><identifier>PMID: 39053076</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Berberine ; Gut microbiota ; Hypertension ; Trimethylamine-N-oxide ; Vascular dysfunction</subject><ispartof>Microbiological research, 2024-10, Vol.287, p.127824, Article 127824</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier GmbH.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c287t-e0ec1b77d8baf3168813954ae85e13418918741c0d9d312f9cca4c900c7d483e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.micres.2024.127824$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39053076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Zhichao</creatorcontrib><creatorcontrib>Shao, Yijia</creatorcontrib><creatorcontrib>Wu, Fang</creatorcontrib><creatorcontrib>Luo, Dangu</creatorcontrib><creatorcontrib>He, Guoyifan</creatorcontrib><creatorcontrib>Liang, Jianwen</creatorcontrib><creatorcontrib>Quan, Xiaoqing</creatorcontrib><creatorcontrib>Chen, Xiehui</creatorcontrib><creatorcontrib>Xia, Wenhao</creatorcontrib><creatorcontrib>Chen, Ye</creatorcontrib><creatorcontrib>Liu, Yue</creatorcontrib><creatorcontrib>Chen, Long</creatorcontrib><title>Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension</title><title>Microbiological research</title><addtitle>Microbiol Res</addtitle><description>The gut microbial metabolite trimethylamine N-oxide (TMAO) is regarded as a novel risk factor for hypertension. Berberine (BBR) exerts cardiovascular protective effects by regulating the gut microbiota-metabolite production pathway. However, whether and how BBR alleviates TMAO-induced vascular dysfunction in hypertension remains unclear. In the present study, we observed that plasma TMAO and related bacterial abundance were significantly elevated and negatively correlated with vascular function in 86 hypertensive patients compared with 46 normotensive controls. TMAO activated endoplasmic reticulum stress (ERS) signaling pathway to promote endothelial cell dysfunction and apoptosis in vitro. BBR (100, 200 mg · kg−1 ·d−1) for 4 weeks ameliorates TMAO-induced vascular dysfunction and ERS activation in a choline-angiotensin II hypertensive mouse model. We found that plasma TMAO levels in 15 hypertensive patients treated with BBR (0.4 g, tid) were reduced by 8.8 % and 16.7 % at months 1 and 3, respectively, compared with pretreatment baseline. The oral BBR treatment also improved vascular function and lowered blood pressure. Faecal 16 S rDNA showed that BBR altered the gut bacterial composition and reduced the abundance of CutC/D bacteria in hypertensive mice and patients. In vitro bacterial cultures and enzyme reaction systems indicated that BBR inhibited the biosynthesis of TMAO precursor in the gut microbiota by binding to and inhibiting the activity of CutC/D enzyme. Our results indicate that BBR improve vascular dysfunction at least partially by decreasing TMAO via regulation of the gut microbiota in hypertension. [Display omitted] •Circulating TMAO and related bacterial abundance were elevated and associated with vascular dysfunction in hypertension.•TMAO activated endoplasmic reticulum stress to promote endothelial cell dysfunction and apoptosis.•BBR reduced plasma TMAO by decreasing abundance of CutC/D bacteria and inhibiting CutC/D enzyme activity in gut microbiota.•BBR had a protective effect against TMAO-induced vascular dysfunction and endoplasmic reticulum stress activation in hypertension.</description><subject>Berberine</subject><subject>Gut microbiota</subject><subject>Hypertension</subject><subject>Trimethylamine-N-oxide</subject><subject>Vascular dysfunction</subject><issn>0944-5013</issn><issn>1618-0623</issn><issn>1618-0623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9Uc1u1DAQthCIbgtvgJCPXLK1Y29sX5BKBbRSUS_t2XLsydarxAm2s1UegbeuVykcOc1hvr-ZD6FPlGwpoc3lYTt4GyFta1LzLa2FrPkbtKENlRVpavYWbYjivNoRys7QeUoHQihXsn6PzpgiO0ZEs0F_vkFsIfoA2AzQ-zGaDAkfTbJzbyJ2S-rmYLMfA24X7MbnEGFfVtmHPX74dXVfQXDj1JtU4uAI2RfiPOCUS7aEJ5Ofns2Cj97g_ZzxKfPY-jEb7AN-WiaIGUIq8h_Qu870CT6-zgv0-OP7w_VNdXf_8_b66q6ytRS5AgKWtkI42ZqO0UZKytSOG5A7oIxTqagUnFrilGO07pS1hltFiBWOSwbsAn1Zdac4_p4hZT34ZKHvTYBxTpoRyYUgipEC5Su0ZE4pQqen6AcTF02JPpWgD3otQZ9K0GsJhfb51WFuB3D_SH-_XgBfVwCUO48eok7WQ7DgfASbtRv9_x1eACtOncw</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Wang, Zhichao</creator><creator>Shao, Yijia</creator><creator>Wu, Fang</creator><creator>Luo, Dangu</creator><creator>He, Guoyifan</creator><creator>Liang, Jianwen</creator><creator>Quan, Xiaoqing</creator><creator>Chen, Xiehui</creator><creator>Xia, Wenhao</creator><creator>Chen, Ye</creator><creator>Liu, Yue</creator><creator>Chen, Long</creator><general>Elsevier GmbH</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20241001</creationdate><title>Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension</title><author>Wang, Zhichao ; Shao, Yijia ; Wu, Fang ; Luo, Dangu ; He, Guoyifan ; Liang, Jianwen ; Quan, Xiaoqing ; Chen, Xiehui ; Xia, Wenhao ; Chen, Ye ; Liu, Yue ; Chen, Long</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c287t-e0ec1b77d8baf3168813954ae85e13418918741c0d9d312f9cca4c900c7d483e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Berberine</topic><topic>Gut microbiota</topic><topic>Hypertension</topic><topic>Trimethylamine-N-oxide</topic><topic>Vascular dysfunction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Zhichao</creatorcontrib><creatorcontrib>Shao, Yijia</creatorcontrib><creatorcontrib>Wu, Fang</creatorcontrib><creatorcontrib>Luo, Dangu</creatorcontrib><creatorcontrib>He, Guoyifan</creatorcontrib><creatorcontrib>Liang, Jianwen</creatorcontrib><creatorcontrib>Quan, Xiaoqing</creatorcontrib><creatorcontrib>Chen, Xiehui</creatorcontrib><creatorcontrib>Xia, Wenhao</creatorcontrib><creatorcontrib>Chen, Ye</creatorcontrib><creatorcontrib>Liu, Yue</creatorcontrib><creatorcontrib>Chen, Long</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Microbiological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Zhichao</au><au>Shao, Yijia</au><au>Wu, Fang</au><au>Luo, Dangu</au><au>He, Guoyifan</au><au>Liang, Jianwen</au><au>Quan, Xiaoqing</au><au>Chen, Xiehui</au><au>Xia, Wenhao</au><au>Chen, Ye</au><au>Liu, Yue</au><au>Chen, Long</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension</atitle><jtitle>Microbiological research</jtitle><addtitle>Microbiol Res</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>287</volume><spage>127824</spage><pages>127824-</pages><artnum>127824</artnum><issn>0944-5013</issn><issn>1618-0623</issn><eissn>1618-0623</eissn><abstract>The gut microbial metabolite trimethylamine N-oxide (TMAO) is regarded as a novel risk factor for hypertension. Berberine (BBR) exerts cardiovascular protective effects by regulating the gut microbiota-metabolite production pathway. However, whether and how BBR alleviates TMAO-induced vascular dysfunction in hypertension remains unclear. In the present study, we observed that plasma TMAO and related bacterial abundance were significantly elevated and negatively correlated with vascular function in 86 hypertensive patients compared with 46 normotensive controls. TMAO activated endoplasmic reticulum stress (ERS) signaling pathway to promote endothelial cell dysfunction and apoptosis in vitro. BBR (100, 200 mg · kg−1 ·d−1) for 4 weeks ameliorates TMAO-induced vascular dysfunction and ERS activation in a choline-angiotensin II hypertensive mouse model. We found that plasma TMAO levels in 15 hypertensive patients treated with BBR (0.4 g, tid) were reduced by 8.8 % and 16.7 % at months 1 and 3, respectively, compared with pretreatment baseline. The oral BBR treatment also improved vascular function and lowered blood pressure. Faecal 16 S rDNA showed that BBR altered the gut bacterial composition and reduced the abundance of CutC/D bacteria in hypertensive mice and patients. In vitro bacterial cultures and enzyme reaction systems indicated that BBR inhibited the biosynthesis of TMAO precursor in the gut microbiota by binding to and inhibiting the activity of CutC/D enzyme. Our results indicate that BBR improve vascular dysfunction at least partially by decreasing TMAO via regulation of the gut microbiota in hypertension. [Display omitted] •Circulating TMAO and related bacterial abundance were elevated and associated with vascular dysfunction in hypertension.•TMAO activated endoplasmic reticulum stress to promote endothelial cell dysfunction and apoptosis.•BBR reduced plasma TMAO by decreasing abundance of CutC/D bacteria and inhibiting CutC/D enzyme activity in gut microbiota.•BBR had a protective effect against TMAO-induced vascular dysfunction and endoplasmic reticulum stress activation in hypertension.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>39053076</pmid><doi>10.1016/j.micres.2024.127824</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0944-5013
ispartof Microbiological research, 2024-10, Vol.287, p.127824, Article 127824
issn 0944-5013
1618-0623
1618-0623
language eng
recordid cdi_proquest_miscellaneous_3084770930
source Elsevier ScienceDirect Journals
subjects Berberine
Gut microbiota
Hypertension
Trimethylamine-N-oxide
Vascular dysfunction
title Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T00%3A44%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Berberine%20ameliorates%20vascular%20dysfunction%20by%20downregulating%20TMAO-endoplasmic%20reticulum%20stress%20pathway%20via%20gut%20microbiota%20in%20hypertension&rft.jtitle=Microbiological%20research&rft.au=Wang,%20Zhichao&rft.date=2024-10-01&rft.volume=287&rft.spage=127824&rft.pages=127824-&rft.artnum=127824&rft.issn=0944-5013&rft.eissn=1618-0623&rft_id=info:doi/10.1016/j.micres.2024.127824&rft_dat=%3Cproquest_cross%3E3084770930%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3084770930&rft_id=info:pmid/39053076&rft_els_id=S0944501324002258&rfr_iscdi=true